These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
1. EXAS reports Q3 earnings at 24 cents, exceeding 7 cents loss estimate. 2. Sales reached $850.739 million, beating the forecast of $810.178 million. 3. FY2025 sales guidance increased to $3.220-3.235 billion from previous estimates. 4. Analysts raised price targets: BTIG to $85, Stifel to $80, Barclays to $77. 5. Shares gained 3.5%, closing at $66.98 after the earnings report.